Target coverage and local recurrences after radiotherapy for sinonasal cancer in Denmark 2008–2015. A DAHANCA study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Maja B. Sharma
  • Kenneth Jensen
  • Jeppe Friborg, Københavns Universitet
  • ,
  • Bob Smulders, Københavns Universitet
  • ,
  • Elo Andersen, Københavns Universitet
  • ,
  • Eva Samsøe, Sjællands Universitetshospital
  • ,
  • Jørgen Johansen, Syddansk Universitet
  • ,
  • Christian R. Hansen, Syddansk Universitet
  • ,
  • Maria Andersen, Aalborg Universitet
  • ,
  • Martin S. Nielsen, Aalborg Universitet
  • ,
  • Mads V. Filtenborg
  • ,
  • Jintao Ren
  • Stine S. Korreman
  • Jens Overgaard
  • Cai Grau

Purpose: The study aimed to investigate the pattern of failure and describe compromises in the definition and coverage of the target for patients treated with curatively intended radiotherapy (RT) for sinonasal cancer (SNC). Methods and Material: Patients treated with curatively intended RT in 2008–2015 in Denmark for SNC were eligible for the retrospective cohort study. Information regarding diagnosis and treatment was retrieved from the national database of the Danish Head and Neck Cancer Group (DAHANCA). Imaging from the diagnosis of recurrences was collected, and the point of origin (PO) of the recurrent tumour was estimated. All treatment plans were collected and reviewed with the focus on target coverage, manual modifications of target volumes, and dose to organs at risk (OARs) above defined constraints. Results: A total of 184 patients were included in the analysis, and 76 (41%) relapsed. The majority of recurrences involved T-site (76%). Recurrence imaging of 39 patients was evaluated, and PO was established. Twenty-nine POs (74%) were located within the CTV, and the minimum dose to the PO was median 64.1 Gy (3.1–70.7). The criteria for target coverage (V95%) was not met in 89/184 (48%) of the CTV and 131/184 (71%) of the PTV. A total of 24% of CTVs had been manually modified to spare OARs of high-dose irradiation. No difference in target volume modifications was observed between patients who suffered recurrence and patients with lasting remission. Conclusion: The majority of relapses after radical treatment of SNC were located in the T-site (the primary tumour site). Multiple compromises with regards to target coverage and tolerance levels for OARs in the sinonasal region, as defined from RT guidelines, were taken. No common practice in this respect could be derived from the study.

OriginalsprogEngelsk
TidsskriftActa Oncologica
Vol/bind61
Nummer2
Sider (fra-til)120-126
Antal sider7
ISSN0284-186X
DOI
StatusUdgivet - 2022

Bibliografisk note

Publisher Copyright:
© 2022 Acta Oncologica Foundation.

Se relationer på Aarhus Universitet Citationsformater

ID: 230367748